• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Hope S Rugo, Roy S. Herbst, +7 authors George Wilding
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 20 August 2005)
  • PURPOSE We studied the safety, clinical activity, and pharmacokinetics (PK) of AG-013736, an oral receptor tyrosine kinase inhibitor of vascular endothelial cell growth factor, platelet-derivedContinue Reading
  • Ezra E. W. Cohen, Lee S. Rosen, +11 authors Roger B. Cohen
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 10 October 2008)
  • PURPOSE Patients with advanced, incurable thyroid cancer not amenable to surgery or radioactive iodine ((131)I) therapy have few satisfactory therapeutic options. This multi-institutional studyContinue Reading
  • Corey J. Langer, Jonathan Harris, +5 authors Kian K. Ang
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 20 October 2007)
  • PURPOSE Recurrent squamous cell carcinoma of the head and neck (SCCHN) or new second primary tumor (SPT) in a previous radiation field, if not curable by surgery or radiation, is almost always fatal.Continue Reading
  • Michael Anthony Carducci, Luna C. Musib, +11 authors Roy S. Herbst
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 1 September 2006)
  • PURPOSE This phase I study was conducted to determine the recommended dose of enzastaurin, an oral protein kinase C beta (PKCbeta) inhibitor, for phase II trials. Secondary objectives wereContinue Reading
  • Desmond Curran, Jordi Giralt, +9 authors James A. Bonner
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 1 June 2007)
  • PURPOSE In this randomized, phase III study, quality of life (QoL) was assessed in patients with locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) after high-doseContinue Reading
  • Michelle D. Williams, Dianna Roberts, +5 authors Adel K. El-Naggar
  • Medicine
  • The American journal of surgical pathology
  • 2007 (First Publication: 1 November 2007)
  • Salivary duct carcinoma (SDC), a rare malignancy, manifests remarkable morphologic and biologic resemblance to high-grade mammary ductal carcinoma. We contend that, similar to mammary ductalContinue Reading